Fresenius Medical Care AG (FMCQF)

36,95 0,00 (0,00%) Alla chiusura: 02:52PM EDT

Fresenius Medical Care AG

Else-KrOener-Strasse 1
Bad Homburg 61352
Germany
49 6172 609 0
https://www.freseniusmedicalcare.com

Settore/i: Healthcare
Settore: Medical Care Facilities
Impiegati a tempo pieno: 119.845

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Ms. Helen Giza	CEO & Chair of Management Board of Fresenius Med. Care Mgmt AG	5,25M	N/D	1968
Mr. Martin Fischer	CFO & Member of the Management Board of Fresenius Medical Care Management AG	944,08k	N/D	1977
Dr. Franklin W. Maddux F.A.C.P.	Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG	2,95M	N/D	1957
Dr. Katarzyna Mazur-Hofsab Ph.D.	Management Board Member for Care Enablement of Fresenius Medical Care Management AG	3,07M	N/D	1963
Mr. Craig Cordola FACHE, M.B.A., M.H.A.	CEO of Care Delivery & Member of Management Board	N/D	N/D	1970
Dr. Dominik Heger	Executive VP and Head of Investor Relations, Strategic Development & Communications	N/D	N/D	N/D
Mr. Joachim Weith	Senior Vice President of Corporate Communications & Governmental Affairs	N/D	N/D	N/D
Dr. Gail-Suzanne Brown	Senior Vice President of Research & Development	N/D	N/D	N/D
Mr. Glenn Slater	Senior Vice President of Manufacturing and Supply Chain Operations	N/D	N/D	N/D
Dr. Wolfgang Kummerle	Senior Vice President - Quality Management International	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Governance aziendale

L'ISS Governance QualityScore di Fresenius Medical Care AG al 1 aprile 2024 è 8. I criteri di valutazione fondamentali sono revisione: 3; Consiglio di Amministrazione: 7; diritti degli azionisti: 1; retribuzione: 9.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.